Agenus Inc — Cash Flow (NASDAQ:AGEN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -139.1 M10.14 M-175.37 M-224.2 M-158.31 M-77.19 M -77.19 M Cash from investing activities -4.44 M-43.15 M-33.61 M3.4 M27 K1.19 M 1.19 M Cash from financing activities 183.85 M225.26 M95.83 M119.87 M122.84 M36.59 M 36.59 M Free cash flow -142.56 M-23.67 M-228.44 M-234.16 M-158.89 M-77.2 M -77.2 M

News

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Agenus (AGEN) is a Great Momentum Stock: Should You Buy?

Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript

Agenus (AGEN) Q4 Earnings and Revenues Surpass Estimates

Agenus reports $4.2M in early access revenue for cancer therapy

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

IBD Stock Of The Day: Ligand Pharma, Biotech's Royalty Arm, Breaks Out

Agenus receives $20M payment from Zydus collaboration

Agenus Inc. (AGEN) Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives Transcript

Agenus expands medical affairs to support early access to cancer therapy

Agenus closes strategic collaboration with Zydus Lifesciences

Agenus appoints CEO Garo Armen as interim CFO and names new accounting officer